Barratt A, Cockburn J, Furnival C, McBride A, Mallon L
Department of Public Health and Community Medicine, University of Sydney, NSW, Australia.
J Epidemiol Community Health. 1999 Nov;53(11):716-20. doi: 10.1136/jech.53.11.716.
To estimate women's expectations of the accuracy of screening mammography and to explore attitudes towards compensation for missed cancers.
Cross sectional survey (by telephone).
Australia; population-based survey conducted in April 1996.
Random sample of women aged 30-69 years. A total of 2935 women completed the Breast Health Survey (adjusted response rate 65%). A random sample of 115 completed this sub-survey on perceived sensitivity of mammographic screening and compensation for missed cancers.
About one third of women (32.2%, 95% CI 23.7, 40.7) had an unrealistically high expectation of the sensitivity of screening mammography, reporting it to be 95% or higher. Approximately 40% of the women (43.5%, 95% CI 34.4, 52.6) thought that screening mammography should pick up all cancers (should have a sensitivity of 100%). Just under half the women (45.2%, 95% CI 36.1, 54.3) said financial compensation should be awarded for a cancer missed by screening mammography even if the cancer was missed as a consequence of the small failure rate of the test. Younger women living in metropolitan areas and women who had realistic expectations of the accuracy of the tests were more likely to favour financial compensation.
Unrealistically high expectations of the sensitivity of screening mammography were common in this group of women. Many women favoured financial compensation for missed cancers even if the cancer was missed solely because of the failure rate of the test. Public education is required to inform women of the limited sensitivity of breast cancer tests but this may not reduce claims for financial compensation when cancers are missed.
评估女性对乳腺钼靶筛查准确性的期望,并探讨她们对漏诊癌症补偿的态度。
横断面调查(通过电话)。
澳大利亚;1996年4月进行的基于人群的调查。
30 - 69岁女性的随机样本。共有2935名女性完成了乳腺健康调查(调整后的回复率为65%)。115名的随机样本完成了关于乳腺钼靶筛查的感知敏感性和漏诊癌症补偿的子调查。
约三分之一的女性(32.2%,95%可信区间23.7, 40.7)对乳腺钼靶筛查的敏感性期望过高,称其为95%或更高。约40%的女性(43.5%,95%可信区间34.4, 52.6)认为乳腺钼靶筛查应能检出所有癌症(敏感性应为100%)。近一半的女性(45.2%,95%可信区间36.1, 54.3)表示,即使癌症因检查的低失败率而漏诊,对于乳腺钼靶筛查漏诊的癌症也应给予经济补偿。居住在大城市地区的年轻女性以及对检查准确性有现实期望的女性更倾向于经济补偿。
在这组女性中,对乳腺钼靶筛查敏感性的不切实际的高期望很常见。许多女性赞成对漏诊癌症给予经济补偿,即使癌症漏诊仅仅是因为检查的失败率。需要开展公众教育,告知女性乳腺癌检查的敏感性有限,但这可能不会减少癌症漏诊时要求经济补偿的诉求。